Value of platelet count and related scoring models in predicting the prognosis of hepatitis B virus-related acute-on-chronic liver failure

Ying TU; Xue LI; Meijuan CHEN; Huaqian XU; Shanhong TANG

doi:10.3969/j.issn.1001-5256.2023.06.009

Volume 39 Issue 6

Jun. 2023

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(6): 1308-1312

PDF( 1996 KB)

Value of platelet count and related scoring models in predicting the prognosis of hepatitis B virus-related acute-on-chronic liver failure

DOI: 10.3969/j.issn.1001-5256.2023.06.009

Ying TU^{1, 2, 3},
Xue LI²,
Meijuan CHEN^{1, 2},
Huaqian XU²,
Shanhong TANG^{1, 2
,
,
,}

1.
Department of Gastroenterology, School of Clinical Medicine, Southwest Medical University, Luzhou, Sichuan 646000, China
2.
Department of Gastroenterology, The General Hospital of Western Theater Command, Chengdu 610083, China
3.
Department of Gastroenterology, The First People's Hospital of Longquanyi District, Chengdu 610100, China

Research funding:

The Science Foundations of Health Commission of Sichuan Province (20PJ180)

More Information

Corresponding author: TANG shanhong, tangshanhong@swjtu.edu.cn (ORCID: 0000-0001-6652-2942)
Received Date: 2022-11-30
Accepted Date: 2022-12-26
Published Date: 2023-06-20

Abstract

Abstract

Objective To investigate the association between platelet count (PLT) and the prognosis of hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF), to establish a new PLT-related scoring model, and to assess its value in predicting the short-term prognosis of HBV-ACLF. Methods A retrospective cohort study was conducted among the patients with HBV-ACLF who were hospitalized and treated in Department of Gastroenterology, The General Hospital of Western Theater Command, from January 2018 to January 2022. Clinical data within 24 hours after admission were collected from all patients, and according to the survival after 180 days of follow-up, the patients were divided into survival group and death group. The independent-samples t test was used for comparison of normally distributed continuous data between groups, and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between groups; the chi-square test was used for comparison of categorical data between groups. The Pearson correlation coefficient was used to investigate the correlation between different indicators, and the logistic regression model was used to analyze the influencing factors for prognosis. The receiver operating characteristic (ROC) curve was used to assess the predictive value of the prognostic model, and the Kaplan-Meier curve analysis was used to investigate the survival condition of the high AIP group and the low AIP group. Results A total of 236 patients were enrolled, with a 180-day survival rate of 75.85% (179/236). Compared with the survival group, the death group had significantly higher age (53.98±10.45 vs 47.44±12.46, P=0.001), international normalized ratio (INR) [1.78 (1.46-2.04) vs 1.47 (1.23-1.68), P < 0.001], total bilirubin [275.60 (165.00-451.45) vs 230.60 (154.90-323.70), P=0.035], Model for End-Stage Liver Disease (MELD) score [21.47 (18.14-24.76) vs 18.67 (15.70-21.62), P < 0.001], and albumin-bilirubin (ALBI) score [-1.06 (-1.64~-0.86) vs-1.32 (-1.73~-1.01), P=0.034], as well as significantly lower PLT [80.00 (50.00~124.50) vs 115.00 (82.00~143.00), P=0.001] and platelet-to-white blood cell ratio (PWR) [13.40 (9.54~20.70) vs 18.49 (13.95~24.74), P=0.001]. The Pearson correlation analysis showed that PLT was negatively correlated with liver cirrhosis and INR (r=-0.332 and -0.194, P < 0.001 and P=0.003). The multivariate logistic regression analysis showed that age (odds ratio [OR]=1.045, 95% confidence interval [CI]: 1.015-1.076), PLT (OR=0.990, 95%CI: 0.983-0.998), and INR (OR=2.591, 95%CI: 1.363-4.925) were independent risk factors for the 180-day prognosis of HBV-ACLF patients. The new predictive model was established as follows: AIP=0.006×age+0.187×INR-0.001×PLT. The AIP scoring model had an area under the ROC curve (AUC) of 0.718 in predicting the 180-day prognosis of HBV-ACLF patients, with a sensitivity of 81.1% and a specificity of 54.1%, while PLT, PWR, LPACLF score, MELD score, and ALBI score had an AUC of 0.673, 0.659, 0.588, 0.647, and 0.578, respectively. The AIP scoring model had an optimal cut-off value of 0.48. The Kaplan-Meier survival analysis showed that the high AIP group had a significantly lower survival rate than the low AIP group (P < 0.001). Conclusion The PLT-related scoring model has a better value than other models in predicting the prognosis of HBV-ACLF, and HBV-ACLF patients with a relatively high PLT level tend to have a high overall survival rate.
- Acute-on-Chronic Liver Failure,
- Hepatitis B virus,
- Blood Platelets,
- Prognosis

FullText(HTML)

References(12)

References

[1]	ARROYO V, MOREAU R, JALAN R. Acute-on-chronic liver failure[J]. N Engl J Med, 2020, 382(22): 2137-2145. DOI: 10.1056/NEJMra1914900.
[2]	LISMAN T, PORTE RJ. Mechanisms of platelet-mediated liver regeneration[J]. Blood, 2016, 128(5): 625-629. DOI: 10.1182/blood-2016-04-692665.
[3]	ARYAL B, YAMAKUCHI M, SHIMIZU T, et al. Therapeutic implication of platelets in liver regeneration -hopes and hues[J]. Expert Rev Gastroenterol Hepatol, 2018, 12(12): 1219-1228. DOI: 10.1080/17474124.2018.1533813.
[4]	TAKAHASHI K, LIANG C, ODA T, et al. Platelet and liver regeneration after liver surgery[J]. Surg Today, 2020, 50(9): 974-983. DOI: 10.1007/s00595-019-01890-x.
[5]	Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007. 中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
[6]	JIE Y, GONG J, XIAO C, et al. Low platelet to white blood cell ratio indicates poor prognosis for acute-on-chronic liver failure[J]. Biomed Res Int, 2018, 2018: 7394904. DOI: 10.1155/2018/7394904.
[7]	XU X, HOU Z, XU Y, et al. The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients[J]. Clin Res Hepatol Gastroenterol, 2021, 45(2): 101482. DOI: 10.1016/j.clinre.2020.06.008.
[8]	GUO J, GONG ZJ, SHI CX. Research progress on hepatitis B virus related acute-on-chronic liver failure with infections[J/CD]. Chin J Liver Dis(Electronic Edition), 2022, 14(3): 5-8. DOI: 10.3969/j.issn.1674-7380.2022.03.002. 郭金, 龚作炯, 石春霞. 乙型肝炎病毒相关慢加急性肝衰竭合并感染研究进展[J/CD]. 中国肝脏病杂志(电子版), 2022, 14(3): 5-8. DOI: 10.3969/j.issn.1674-7380.2022.03.002.
[9]	DUSEJA A, SINGH SP. Toward a better definition of acute-on-chronic liver failure[J]. J Clin Exp Hepatol, 2017, 7(3): 262-265. DOI: 10.1016/j.jceh.2017.05.002.
[10]	GAO XY, CHEN L, GAN JH. Value of Model for End-Stage Liver Disease score combined with platelet-to-white blood cell ratio in predicting the prognosis of patients with hepatitis B virus-associated acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37(5): 1070-1074. DOI: 10.3969/j.issn.1001-5256.2021.05.019. 高心怡, 陈丽, 甘建和. MELD评分联合血小板/白细胞比值对HBV相关慢加急性肝衰竭患者预后的预测价值[J]. 临床肝胆病杂志, 2021, 37(5): 1070-1074. DOI: 10.3969/j.issn.1001-5256.2021.05.019.
[11]	SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update[J]. Hepatol Int, 2019, 13(4): 353-390. DOI: 10.1007/s12072-019-09946-3.
[12]	SHI Y, YANG Y, HU Y, et al. Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults[J]. Hepatology, 2015, 62(1): 232-242. DOI: 10.1002/hep.27795.

Relative Articles

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	涂雨落，孙克伟. 基于“阳黄-阴阳黄-阴黄”辨证论治模式治疗HBV相关慢加急性肝衰竭的临床疗效分析. 中国中西医结合消化杂志. 2024(03): 195-202 .
2.	张冬梅，李婷，陈素玲. FIB-4、总胆红素及GPRI水平与肝癌切除术后肝功能衰竭并发症的相关性. 临床和实验医学杂志. 2024(08): 830-833 .
3.	韩肇丹，许军，李芃芃，赵卫娟. AARC-ACLF评分联合NLR对HBV相关慢加急性肝衰竭短期预后的评估价值. 肝脏. 2024(05): 538-541 .
4.	匡竞，滕双芩，申彤彤，闫怡然，王玮，申川，赵彩彦. 肝硬化门脉性肺动脉高压危险因素分析及预测模型构建. 临床肝胆病杂志. 2024(09): 1802-1806 . 本站查看
5.	张仕华，柏承志，李春燕，徐理茂，徐华谦，汤善宏. 老年HBV相关慢加急性肝衰竭预后的危险因素及风险预测列线图模型构建. 临床肝胆病杂志. 2024(10): 1976-1984 . 本站查看
6.	马万龙，马玉，王伟红，丁向春，焦运，刘帅伟，海龙. 慢加急性肝衰竭患者预后生存分析. 中华肝脏病杂志. 2023(10): 1051-1055 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2) / Tables(3)

Get Citation

PDF

XML

Article Metrics

Article views (394) PDF downloads(47)

Value of platelet count and related scoring models in predicting the prognosis of hepatitis B virus-related acute-on-chronic liver failure

DOI: 10.3969/j.issn.1001-5256.2023.06.009